The 2018 iCMLf Goldman Prize is awarded to Professor Jorge Cortes

'Jorge has led many of the most important CML trials over the past decade and is now regarded as the pre-eminent world expert in CML management. He has also tirelessly disseminated his unique expertise to colleagues at his own centre and around the world.' 
(Timothy Hughes, Chairman of the iCMLf)

Jorge Cortes, Professor of Medicine and Deputy Chair at the Department of Leukemia at the MD Anderson Cancer Center, has been awarded the 2018 iCMLf Goldman Prize. The award celebrates his globally recognised expertise and life-long commitment to the management of patients with CML.

Professor Cortes’ clinical interest focuses on new drug development and the management of patients with CML, other leukemias and myeloproliferative disorders. He led many of the most important CML trials over the past decades including the development of three drugs that were approved for the treatment of CML. Dr Cortes is an internationally recognised expert in CML management and what drives him personally is to continuously look for new opportunities for his patients.
His efforts have helped to advance the way CML patients are now being treated worldwide.

Jorge Cortes has always been keen to share his knowledge and scientific findings with the scientific community. He is a tireless author with over 900 peer-reviewed medical publications in top-tier journals. He has also authored several books and book chapters in prestigious publications such as Cancer Medicine. Dr Cortes is an Associate Editor for Blood and serves in the Editorial Board of the Journal of Clinical Oncology, Leukemia, Clinical Cancer Research, Leukemia & Lymphoma and the American Journal of Hematology.

As a founding member of the iCMLf Jorge has decisively shaped the strategy of the Foundation from its beginning. Since 2014 he has chaired the Annual John Goldman Conference on CML, which is jointly run by the iCMLf and the European School of Hematology.

Jorge Cortes is Professor of Medicine and Deputy Chair at the Department of Leukemia at MD Anderson Cancer (University of Texas) in Houston where he directs the CML and AML programs. He received his medical degree from the Universidad Nacional Autónoma de Mexico, Mexico City, and completed fellowships in hematology at the Instituto Nacional de la Nutrición Salvador Zubirán in Mexico City, Mexico, the University of Texas Health Science Center in Houston and the MD Anderson Cancer Center in Houston.  

Learn more about Jorge Cortes here